Australia markets open in 6 hours 11 minutes

Miromatrix Medical Inc. (MIRO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.92-0.22 (-3.04%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close7.14
Open7.15
Bid6.60 x 1000
Ask8.77 x 2200
Day's range6.92 - 7.15
52-week range6.47 - 16.52
Volume2,126
Avg. volume22,276
Market cap140.217M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Miromatrix Reports Third Quarter 2021 Results

    EDEN PRAIRIE, Minn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported third quarter 2021 financial results. Business Highlights Completed an initial public offering of 5.5 million shares, raising approximately $49 million in gross proceeds;Hired accomplished scientist and product developer, Dr. John Barry, as Vice P

  • GlobeNewswire

    Miromatrix to Report Third Quarter 2021 Financial Results

    EDEN PRAIRIE, Minn., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financial results for the third quarter 2021 after market close on Monday, November 15, 2021. Company management will host a corresponding conference call beginning at 3:30 pm Central Time / 4:30 pm Eastern Time. Indi

  • GlobeNewswire

    Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal

    Preclinical study of clinically relevant liver transplants advances the decellularization/recellularization approach, representing a key advancement in new therapies for acute and chronic liver failure patientsEDEN PRAIRIE, Minn., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced it has successfully completed the fi